Syringes Market

Market Overview:

The global syringes market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.29% during 2024-2032.

Syringes are medical devices used by healthcare professionals to withdraw fluid from the body or inject medication through intravenous (IV) or intramuscular ways into the bloodstream. They assist in managing the medical conditions of people, including psoriasis, allergies, arthritis, cancer, diabetes, hepatitis, infertility, migraines, multiple sclerosis, osteoporosis, blood clotting disorders, and human immunodeficiency virus (HIV). Several manufacturers are currently adopting advanced manufacturing processes and quality assurance procedures to produce syringes that provide research and development (R&D) personnel with superior accuracy and precision during auto sampling.

Syringes Market Trends:

Governments of numerous countries are encouraging the fast and safe vaccination of people to reduce their probability of contracting coronavirus disease (COVID-19). This represents one of the key factors driving the need for effective syringes to meet vaccination targets. Apart from this, the growing prevalence of chronic diseases and the increasing healthcare-associated infection (HAI) cases are catalyzing the adoption of disposable syringes that are cost-effective, ready to use, and made of plastic. In addition to this, a significant rise in the percentage of people who are undergoing surgical interventions is augmenting the demand for single-use syringes for delivering anesthetics. Besides this, various initiatives, such as installing sharp containers in public places, undertaken by health agencies to address the increasing number of used syringes and promote safe injection practices are impelling the growth of the market. Furthermore, as farm animals are commonly exposed to diseases that can spread to humans, the increasing consumption of animal-derived products and the rising concerns about food safety are escalating the demand for combined vaccines and syringes. This can also be attributed to the growing adoption of companion animals and the emerging pet ownership and humanization trends.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global syringes market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, material, usage, distribution channel and end user.

Breakup by Product:

• General Syringes
• Specialized Syringes
  • Insulin Syringes
  • Tuberculin Syringes
  • Allergy Syringes
• Others
   

Breakup by Material:

• Glass Syringes
• Polymer Syringes
   

Breakup by Usage:

• Disposable Syringes
  • Conventional Syringes
  • Safety Syringes
  • Prefilled Syringes
• Reusable Syringes
   

Breakup by Distribution Channel:

• Offline
• Online
   

Breakup by End User:

• Hospitals and Clinics
• Diagnostic Centers
• Speciality Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Pfizer Inc., Retractable Technologies Inc., Schott AG, Smiths Group plc, Terumo Corporation and Thomas Scientific LLC.

Report Coverage: